Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases

Muscle and Nerve

Volumn 21, Issue 1, 1998, Pages 55-62

  Chassande, Bénédicte ^a   Léger, Jean Marc ^a   Younes Chennoufi, Amena Ben ^b   Bengoufa, Djaouida ^c   Maisonobe, Thierry ^b   Bouche, Pierre ^b   Baumann, Nicole ^b  

^a Department of Neurology ^*

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Anti MAG antibodies; Antisulfatide antibodies; M protein

Indexed keywords

M PROTEIN; M PROTEIN ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AUTOANTIBODIES; AXONS; DISEASE PROGRESSION; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; MYELOMA PROTEINS; NEURAL CONDUCTION; PARAPROTEINEMIAS; PARESTHESIA; PATIENT SELECTION; PERIPHERAL NERVOUS SYSTEM DISEASES; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 0031972917     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F     Document Type: Article

References (51)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
2. Antoine JC, Steck A, Michel D: Neuropathie périphérique mortelle à prédominance motrice associée à une IgM monoclonale anti-MAG. Rev Neurol 1993;149:496-499.
3. Bain PC, Britton TC, Jenkins IH, Thompson PD, Rothwell JC, Thomas PK, et al.: Tremor associated with benign IgM para-proteinaemic neuropathy. Brain 1996;119:789-799.
4. Ben Younes-Chennoufi A, Léger JM, Hauw JJ, Preud'homme JL, Bouche P, Aucouturier P, et al.: Ganglioside GD1b is the target antigen for a biclonal IgM in a case of senory-motor axonal polyneuropathy: involvement of N-acetylneuraminic acid in the epitope. Ann Neurol 1992;32:18-23.
5. Ben Younes-Chennoufi A, Rozier A, Dib M, Bouche P, Lacomblez L, Mombo N, et al.: Anti-sulfoglucuronyl paragloboside IgM antibodies in amyotrophic lateral sclerosis. J Neuroimmunol 1995;57:111-115.
6. Blume G, Pestronk A, Goodnough LT: Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide. Ann Neurol 1995;45:1577-1580.
7. Bouche P, Moulonguet A, Ben Younes-Chennoufi A, Adams D, Baumann N, Meininger V, et al.: Multifocal motor neuropathy with conduction blocks: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995;59:38-14.
8. Braun PE, Frail DE, Latov N: Myelin associated glycoprotein is the antigen for monoclonal IgM in polyneuropathy. J Neurochem 1982;39:1261-1265.
9. Brindel JL, Preud'homme JM, Vallat JM, Vincent D, Vasquez JL, Jauberteau MO: Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy. Neurosci Lett 1994;181:103-106.
10. Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, Scarlato G: Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol 1996;39:539-543.
11. Chiba A, Kusunoki S, Shimizu T, Kanazawa I: Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller-Fisher syndrome. Ann Neurol 1992;31:677-679.
12. Chou KH, Ilyas AA, Evans JE, Costello C, Quarles RH, Jungalwala FB: Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraprotein in neuropathy. J Biol Chem 1986;261:11717-11725.
13. Dalakas MC, Quarles RH: Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens? Ann Neurol 1996;39:419-422.
14. Dellagi K, Dupouey P, Brouet JC, Billecoq A, Gomez D, Clauvel JP, Seligmann M: Waldenström's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients. Blood 1983;62:280-285.
15. Dubas F, Pouplard-Barthelaix A, Delestre F, Emile J: Polyneuropathies avec garnmapathie monoclonale IgM: 12 cas. Rev Neurol 1987;143:670-683.
16. Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J: Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological, pathological findings and response to treatment in 33 cases. J Neurol 1996;243:34-43.
17. Gabriel JM, Erne B, Miescher GC, Miller SL, Vital A, Vital C, Steck A: Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain 1996;119:775-787.
18. Garcin R, Rondot P: Les aspects névritiques initiaux de la macroglobulinémie de Waldenström. Psychiatry Neurol Neurochir 1963;66:318-325.
19. Gosselin S, Kyle RA, Dyck PJ: Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991;30:54-61.
20. Hays AP, Latov N, Takatsu M, Sherman WH: Experimental demyelination of nerve induced by serum of patients with neuropathy and anti-MAG IgM M-proteins. Neurology 1987;37:242-256.
21. Ilyas AA, Cook SD, Dalakas MC, Mithen FA: Anti-MAG IgM paraprotein from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol 1992;37:85-92.
22. Ilyas AA, Quarles RH, Dalakas MC, Brady RO: Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins. Proc Natl Acad Sci (USA) 1985;82:6697-6700.
23. Jauberteau MO, Hénin D, Bouche P, Vallat JM, Dumas M, Dellagi S, et al.: Etude des anticorps antiglycolipides au cours des dysglobulinémies monoclonales à IgM associées à une neuropathic périphérique. Rev Neurol 1988;144:474-480.
24. Kaku A, England JD, Summer AJ: Distal accentuation of conduction slowing in polyneuropathy associated with myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-947.
25. Kelly JJ: The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies. Muscle Nerve 1990;1:1113-1117.
26. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I: Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 1996;39:424-431.
27. Kyle RA: "Benign" monoclonal gammopathy. After 20 to 35 years of follow-up. Mayo Clin Proc 1993;68:26-36.
28. Latov N, Sherman WH, Nemni R, Galassi G, Shyong JS, Penn AS, et al.: Plasma cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral nerve myelin. N Engl J Med 1980;303:518-521.
29. Léger JM, Ben Younes-Chennoufi A, Chassande B, Davila G, Bouche P, Baumann N, Brunet P: Human immunoglobulin treatment of mutlifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 1994;57(suppl):46-49.
30. Léger JM, Ben Younes-Chennoufi A, Zuber M, Bouche P, Jauberteau MO, Dormont D, et al.: Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical study. J Neurol Neurosurg Psychiatry 1992;55:112-115.
31. Léger JM, Mariette X, Chastang C, Clavelou P, Louboutin JP, Bouche P, Brouet JC for the IgM-Associated Polyneuropathy Study Group: A randomized trial comparing alpha-interferon and intravenous immunoglobulin in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 1996;46(suppl 2):A380.
32. Maisonobe T, Chassande B, Vérin M, Jouni M, Léger JM, Bouche P: Chronic dysimmune demyelinating polyneuropathy: a clinical and elcctrophysiological study of 93 patients. J Neurol Neurosurg Psychiatry 1996;61:36-42.
33. Nemni R, Fazio R, Quattrini A, Lorenzetti I, Mamoli D, Canal N: Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy. J Neuroimmunol 1993;43:79-86.
34. Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, et al.: Frequency and clinical correlates of antineural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994;36:416-424.
35. Notermans NC, Lokhorst HM, Franssen H, van der Graaf Y, Teunissen LL, Jennekens FGI, et al.: Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology 1996;47:1227-1233.
36. Notermans NC, Wokke JHJ, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FGI: Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 1994;117:1385-1393.
37. Oksenhendler E, Chevret S, Léger JM, Louboutin JP, Bussel A, Brouet JC for the IgM-Associated Polyneuropathy Study Group: Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neurosurg Psychiatry 1995;59:243-247.
38. Pestronk A, Griffin J, Feldman EL, Cornblath D, Trotter J, Zhu S, et al.: Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991;41:357-362.
39. Pradat PF, Mari I, Chassande B, Bequet D, Baumann N, Bouche P, Léger JM: Motor peripheral neuropathy associated with anti-MAG monoclonal IgM. J Neurol 1996;243(suppl 2):S65.
40. Sherman WH, Latov N, Hays AP, Takatsu M, Nemni R, Galasi G, Osserman EF: Monoclonal IgM K antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis. Neurology 1983;33:192-201.
41. Simmons Z, Albers JW, Bromberg MB, Feldman EL: Long-term follow-up of patients with chronic inflammatory demye-Hnating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995;118:359-368.
42. Smith IS: The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinemia: a clinical and neurophysiological study. Brain 1994;11:949-957.
43. Smith IS, Kahn SN, Lacey BW, King RHM, Eames RA, Whybrew DJ, Thomas PK: Chronic demyelinating neuropathy associated with benign IgM paraproteinemia. Brain 1983;106:169-195.
44. Steck A, Murray N, Dellagi K, Brouet JC, Seligmann M: Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol 1987;22:764-767.
45. Suarez GA, Kelly JJ: Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993;43:1304-1308.
46. Tatum AH: Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 1993;3:502-506.
47. Vallat JM, Jauberteau MO, Bordessoule D, Yardin C, Preux PM, Couratier P: Link between neuropathy and monoclonal dysglobulinemia: a study of 66 cases. J Neurol Sci 1996;137:124-130.
48. van den Berg LH, Hays AP, Nobile-Orazio E, Kinsella LJ, Manfredini E, Corbo M et al.: Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 1996;19:637-643.
49. van den Berg LH, Lankamp CLAM, de Jager AEJ, Notermans NC, Sodaar P, Marrink J, et al.: Anti-sulphatide antibodies in peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993;56:1164-1168.
50. Willison HJ: Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psychiatry 1994;57:1303-1307.
51. Willison HJ, Paterson G, Veitch J, Inglis G, Barnett SC: Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 1993;56:1178-1183.